Clinical trial
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by…
NCT00414362 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00414362 |
|---|---|
| Title | Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin |
| Official title | Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Japan Health Sciences Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Urinary Tract Infection, Fluoroquinolone, Bacteremia |
| Enrollment | 1,000 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2017 |
| Completion | Jun 1, 2017 |
| First posted | Dec 21, 2006 |
| Last update posted | Jun 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: